Vimizim

Elosulfase Alfa

6.2 Moderate risk

Vimizim & Pyrexia

12.1%

of users reported Pyrexia

75.9%

also reported Hospitalization

50.8%

are men

Most common medical consequences

Hospitalization
75.9%
Severe reaction
19.0%
Death
1.7%
Life-threatening condition
1.7%
Disability
1.7%

Have you experienced any negative side effects from this medication?

Vimizim: general information

Most common side effects (73)

Most commonly affected ages

0 - 9 years
30.2%
10 - 19 years
39.3%
20 - 29 years
16.9%
30 - 39 years
7.7%
40 - 49 years
5.9%